Using a natural chemical humans and other animals produce in
their bodies, scientists have for the first time induced hibernation
in mammals, putting mice into a state similar to suspended animation
for up to six hours and then bringing them back to normal life.
The breakthrough suggests humans along with other mammals might
harbor a mostly unused ability to hibernate on demand. Further
research into the phenomenon could lead to medical advances, such as
buying time for humans awaiting an organ transplant, scientists
said.
"We are, in essence, temporarily converting mice from
warm-blooded to cold-blooded creatures, which is exactly the same
thing that happens naturally when mammals hibernate," said lead
researcher Mark Roth of the Fred Hutchinson Cancer Research Center
in Seattle.
During the induced hibernation, cells virtually stopped working,
reducing the rodents' need for oxygen.
"We think this may be a latent ability that all mammals have -
potentially even humans - and we're just harnessing it and turning
it on and off, inducing a state of hibernation on demand," Roth
said.
The results are detailed in the April 22 issue of the journal
Science.
Humans already hibernate
Squirrels, bears, snakes and many other animals hibernate
naturally, some more deeply than others. Humans have been known to
hibernate by accident, Roth and his colleagues point out.
A Norwegian skier was rescued in 1999 after being submerged in
icy water for more than an hour. She had no heartbeat and her body
temperature was 57 degrees Fahrenheit (normal is 98.6). She
recovered.
Canadian toddler Erika Nordby wandered outside at night and
nearly froze to death in 2001. She wore only a diaper and T-shirt.
It was minus 11 Fahrenheit (-24 Celsius). When found, her heart had
stopped beating for two hours and her body temperature was 61
degrees. She suffered severe frostbite but required no amputations
and otherwise recovered.
"Understanding the connections between random instances of
seemingly miraculous, unexplained survival in so-called clinically
dead humans and our ability to induce - and reverse - metabolic
quiescence in model organisms could have dramatic implications for
medical care," Roth said. "In the end I suspect there will be
clinical benefits and it will change the way medicine is practiced,
because we will, in short, be able to buy patients time."
Back from the dead?
Already there are companies that will gladly freeze the dead in
hopes some way of curing and reviving them might develop in the
future. The field is called cryonics. So far, no one has been
brought back.
The trick with the mice didn't require freezing. Instead, the
rodents breathed air laced with hydrogen sulfide, a chemical
produced naturally in the bodies of humans and other animals. Within
minutes, they stopped moving and soon their cell functions
approached total inactivity.
Humans use hydrogen sulfide to "buffer our metabolic
flexibility," Roth explained. "It's what allows our core temperature
to stay at 98.6 degrees, regardless of whether we're in Alaska or
Tahiti."
In extreme doses, the hydrogen sulfide is thought to bind to
cells in place of oxygen. The organism's metabolism shuts down. Upon
breathing normal air again, the mice "quickly regained normal
function and metabolic activity with no long-term negative effects,"
the researchers report. They plan to test the technique on larger
mammals next.
Practical uses
"Hibernating humans and space travel aside," Roth told
LiveScience, "we hope that 'metabolic flexibility' can be used to
enhance trauma care, surgical outcome, and organ transplant."
Among the first applications in humans might be to reduce severe
fevers, when a patient is near death. Clinical trials for such a
procedure could begin in five years, the scientists say.
"We believe we know how to flip the breaker on the patient's
furnace," Roth said. "If they have a fever, we believe we know how
to stop it on a dime."
For cancer patients, Roth speculated that temporarily eliminating
oxygen dependence in healthy cells could make them less vulnerable
targets to radiation and chemotherapy.
"Right now in most forms of cancer treatment we're killing off
the normal cells long before we're killing off the tumor cells," he
said. "By inducing metabolic hibernation in healthy tissue we'd at
least level the playing field."
Eric Blackstone, a graduate research assistant in Roth's
laboratory, was lead author of the journal paper.
Related Stories
Visit LiveScience.com
for more daily news, views and scientific inquiry with an original,
provocative point of view. LiveScience reports amazing, real world
breakthroughs, made simple and stimulating for people on the go.
Check out our collection of Image
Galleries, Interactive
Features, Trivia
and more.